Brain and erythrocyte anion transporter protein, band 3, as a marker for alzheimer’s disease: Structural changes detected by electron microscopy, phosphorylation, and antibodies

Gerontology

Volumn 43, Issue 1-2, 1997, Pages 44-66

  Kay, Marguerite M B ^a,b   Goodman, Joseph ^b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b Intl Found for Biomed Aging Res   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer s blood test; Human monoclonals; Senescent cell antigen; Transport

Indexed keywords

ANTIBODY; AUTOANTIBODY; CARRIER PROTEIN; CELL ANTIGEN; ERYTHROCYTE BAND 3 PROTEIN; GLUCOSE; MARKER; MONOCLONAL ANTIBODY; PHOSPHORUS 32; POLYCLONAL ANTIBODY;

ALZHEIMER DISEASE; ANION TRANSPORT; ARTICLE; BLOOD CELL; BRAIN; ELECTRON MICROSCOPY; ERYTHROCYTE; GLUCOSE TRANSPORT; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SERODIAGNOSIS;

AGING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BRAIN CHEMISTRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HUMANS; IMMUNOBLOTTING; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY;

EID: 0031021051     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213835     Document Type: Article

References (121)

1. Kav MMB, Tracey CM, Goodman JR, Cone JC, Bassel PS: Polypeptides immunologically related to erythrocyte band 3 are present in nucleated somatic cells. Proc Natl Acad Sei USA 1983:80:6882-6886.
2. Kay MM, Bosnian G, Notter M, Coleman P: Life and death of neurons: The role of senescent cell antigen. Ann NY Acad Sci 1988:521: 155-169.
3. Dcmuth DR, Showe LC, Balia mine M, Palumbo A, Fraser PJ, Cioe L, Rovera G, Curtis PJ: Cloning and structural characterization of a human non-erythroid band 3-Iike protein. EMBOJ 1986:5:1205-1214.
4. Kay MM, Hughes J, Zagon I, Lin FB: Brain membrane protein band 3 performs the same functions as erythrocyte band 3. Proc Natl Acad Sei USA 1991:88:2778-2782.
5. Kay MMB: Drosophila to bacteriophage to erythrocyte: The erythrocyte as a model for molecular and membrane aging of terminally differentiated cells. Gerontology 1991: 37:5-32.
6. Kay MMB, Hughes JE, Zagon I: Aging of cell membrane molecules: Band 3 and senescent cell antigen in neural tissue: in Beyreuther K, Schettler G (eds): Molecular Mechanisms of Aging. Berlin. Springer. 1990. pp 110-123.
7. Drenckhahn D, Zinke K, Schauer U, Appell KC, Low PS: Identification of immunoreactivc forms of human erythrocyte band 3 in noncry-throid cells. Eur J Cell Biol 1984:34: 144-150.
8. Drenckhahn D, Schulter K, Allen DP, Bennett V: Colocalization of band 3 with ankvrin and spectrin at the basal membrane of intercalated cells in the rat kidney. Science 1985: 230:1287-1289.
9. Karniski LP, Jennings ML: Identification and partial purification of a band 3-like protein from rabbit renal brush border membranes. J Biol Chcm 1989:264:4564-4570.
10. Kellokumpu S, Neff L, Jamsa-Kello-kumpu S, Kopito R, Baron R: A 115-kD polypeptide immunologi-cally related to erythrocyte band 3 is present in Golgi membranes. Science 1988:242:1308-1311.
11. Lindsey AE, Schneider K, Simmons DM, Baron R, Lee BS, Kopito RR: Functional expression and subcellu-lar localization of an anion exchanger cloned from choroid plexus. Proc Natl Acad Sci USA 1990:87: 5278-5282.
12. Schuster VL, Bonsib SM, Jennings ML: Two types of collecting duct mitochondria-rich (intercalated) cells: lectin and band 3 cytochemistry. Am J Physiol 1986:251:0347-C355.
13. Schluter K, Drcnchhahn D: Co-clustering of denatured hemoglobin with band 3; its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes. Proc Natl Acad Sci 1986;83:6137-5141.
14. Wolpaw EW, Martin DL: A membrane protein in LRM55 glial cells cross-reacts with antibody to the anion exchange carrier of human erythrocytes. Ncurosci Lett 1986; 67:42-47.
15. Garlid K, Beavis A: Evidence for the existence of an inner membrane anion channel in mitochondria. Bio-chim Biophys Acta 1986:853:187-204.
16. Havenga MJ, Bosnian GJ, Appcl-hans II, Dc Grip WJ: Expression of the anion exchanger (AE) gene family in human brain: Identification of a new AE protein: AE0. Brain Res Mol Brain Res 1994;25:97-104.
17. Tanner MJA: Molecular and cellular biology of the erythrocyte anion exchanger (AEI). Semin Hematol 1993;30:34-57.
18. Tanner MJA, Martin PG, High S: The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence. Biochem J 1988:256:703-712.
19. Yannoukakos D, Stuart-Tillcy A, Fernandez HA, Fey P, Duyk G, Alp-er SL: Molecular cloning, expressioN, and chromosomal localization of two isoforms of the AE3 anion exchanger from human heart. Circ 1994;75:603-614.
20. Alper SL: The band 3-relatcd anion exchanger (AE) gene family. Annu Rev Physiol 1991:53:549-564.
21. Alper sI, Kopito RR, Lodish HF: A molecular biological approach to the study of anion transport. Kidney Int 1987;23(suppl):S117-S133.
22. Kopito RR, Lee BS, Simmons DM, Lindsey AE, Morgans CW, Schneider K: Regulation of intracellular pH by a neuronal homolog of the erythrocyte anion exchanger. Cell 1989: 59:927-937.
23. Kopito RR: Molecular biology of the anion exchanger gene family. Im RevCytol 1990:123:177-199.
24. Morgans CW, Kopito RR: Generation of truncated brain AE3 isoforms by alternate mRNA processing. J Cell Sci 1993:106:1275-1282.
25. Kim H-RC, Kennedy BS, Engel JD: Two chicken erythrocyte band 3 mRNAs arc generated by alternative transcriptional initiation and differential RNA splicing. Mol Cell Biol 1989:9:5198-5206.
26. Kim CS, Roc CR, Mann JD, Breese GR: Octanoic acid produces accumulation of monoamine acidic metabolites in the brain: Interaction with organic anion transport at the choroid plexus. J Ncurochcm 1992; 58:1499-1503.
27. Kudrycki KH, Shull GE: Rat kidney band 3 CI"/HC03" exchanger mRNA is transcribed from an alternative promoter. Am J Physiol 1993;264:F540-F547.
28. Yannoukakos D, Vasseur C, Blou-quit Y, Bursaux E, Wajcman H: Primary structure of the cytoplasmic domain of human erythrocyte protein band 3: Comparison with its sequence in the mouse. Biochim BiophysActa 1989;998:43-49.
29. Kay M, Cover C, Schluter S, Bernstein R, Marchalonis J: Band 3. the anion transporter, is conserved during evolution: Implications for aging and vertebrate evolution. Cell Mol Biol 1995;41:833-842.
30. Kay MMB: Senescent cell antigen: A red cell aging antigen; in Garratty G (ed): Red Cell Antigens and Antibodies. Arlington. American Association of Blood Banks. 1986, pp 35-82.
31. Kay MMB, Goodman JR, Notter M, Bosman GJCM: Neoplastic cells preferentially express senescent cell antigen following cellular differentiation. Blood 1986:68:190a.
32. Notter MFD, Kay MMB, Leary JF: Neuroblastoma cell lines express band 3 glycoprotein preferentially during cellular differentiation. Soc Neurosci Abstr 1986:12:1458.
33. Kay MMB, Sorensen K, Wong P, Bolton P: Antigenicity, storage and aging: Physiologic autoantibodics to cell membrane and scrum proteins and the senescent cell antigen. Mol Cell Biochem 1982:49:65-85.
34. Kay MMB: Senescent cell antigen, band 3, and band 3 mutations in cellular aging. Biomed Biochim Acta 1990;49:212-217.
35. Kay MMB, Goodman J, Goodman S, Lawrence C: Membrane protein band 3 alteration associated with neurologic disease and tissue reactive antibodies. Clin Exp Iramuno-genet 1990:7:181-199.
36. Kay MMB, Goodman J, Lawrence C, Bosman G: membrane channel protein abnormalities and autoantibodics in neurological disease. Brain Res Bull 1990:24:105-111.
37. Kay MMB: Band 3 in aging and neurological disease. Ann NY Acad Sci 1991;621:179-205.
38. Kay MMB: Senescent cell antigen and band 3 in aging and disease. Prog Cell Res 1992;2:245-250.
39. Kay M, Cover C, Goodman J: Post-translational modifications of brain and erythrocyte band 3 during aging and disease. Cell Mol Biol 1996;in press.
40. Saitoh T, Masliah E, Baum L, Sundsmo M, Flanagan L, Vikram-kumar R, Kay MMB: Degradation of proteins in the membrane-cyto-skeleton complex in Alzheimer’s disease. Ann NY Acad Sc: 1992; 674:180-192.
41. Bosman G, Kay MMB: Anion transport by both human and rat red cells is effected by cellular aging. Clin Res 1986:34:452a.
42. Bosman GJ, Kay MM: Erythrocyte aging: A comparison of model systems for simulating cellular aging in vitro. Blood Cells 1988:14:19-46.
43. Kay MMB: Band 3. the predominant transmembrane polypeptide, undergoes proteolytic degradation as cells age. Monogr Dev Biol 1984: 17:245-253.
44. Cover C, Poulin JE, Gustafson MR, Gamble DN, Kay MMB: Posttrans-lational changes in Band 3 in mouse brain following treatment with ergo-loid mesylates, comparison to changes observed in Alzheimer's disease. Life Sci 1996:58:655-664.
45. Kay MM, Goodman SR, Sorensen K, Whitfield CF, Wong P, Zaki L: Senescent cell antigen is immuno-logically related to band 3. Proc Natl Acad Sci USA 1983;80:1631-1635.
46. Kay MM, Bosman GJ, Shapiro SS, Bendich A, Bassel PS: Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to erythrocytes. Proc Natl Acad Sci USA 1986:83:2463-2467.
47. Kay MM, Bosman GJ, Johnson GJ, Beth AH: Band-3 polymers and aggregateS, and hemoglobin precipitates in red cell aging. Blood Cells 1988:14:275-295.
48. Kay MM, Flowers N, Goodman J, Bosman G: Alteration in membrane protein band 3 associated with accelerated erythrocyte aging. Proc Natl Acad Sci USA 1989:86:5834-5838.
49. Kay MM, Marchalonis JJ: Hypothesis: Synthetic aging antigen can be used to manipulate cellular lifespan. Life Sci 1991:48:1603-1608.
50. Kay MM: Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigen. Cell Mol Biol 1993:39:131-153.
51. Kay MMB: Role of physiologic autoantibody in the removal of senescent human red cells. J Supramol Struct 1978;9:555-567.
52. Kay MMB: Mechanism of removal of senescent red cells. Gerentologist 1974;14:33.
53. Kay MMB: Mechanism of removal senescent cells by human macrophages in situ. Proc Natl Acad Sci USA 1975:72:3521-3525.
54. Kay MMB: Isolation ofthe phagocytosis inducing lgG-binding antigen on senescent somatic cells. Nature 1981:289:491-494.
55. Kay MMB: Cells. signals and receptors: The role of physiological autoantibodics in maintaining homeostasis. Adv Exp Med Biol 1980:129: 171-200.
56. Kay MMB: The IgG autoantibodv binding determinant appearing on senescent cells resides on a 62.000 MW peptide. 9th Int Symp Struct Function Erythroid Cells. Berlin. GDR, Acta Biol Med Germ 1981: 40:385-391.
57. Kay MMB: Molecular aging: A termination antigen appears on senescent cells. 29th Annu Coll Protides Biol Fluids. Belgium. Protides Biol 1982;29:238-325.
58. Kay MMB: Isolation of the antigen appearing on senescent somatic cells; in Developmental Immunology: Clinical Problems and Aging. New York. Academic Press. 1982: pp 269-276.
59. Kay MMB: Appearance of a terminal differentiation antigen on senescent and damaged cells and its implications for physiologic autoantibodies. Biomembranes 1983:119-150.
60. Kay MMB: Localization of senescent cell antigen on band 3. Proc Natl Acad Sci USA 1984:81:5753-5757.
61. Kay MMB: Immune system: Expression and regulation of cellular aging; in Bergener M, Ermini M, Stachclin HB (eds): Thresholds in Aging. London, Academic Press. 1985. pp 59-82.
62. Kay MMB: Immunology of aging: in Chandra RK (ed): Nutrition. Immunity and Illness in the Elderly. New York. Pergamon Press. 1985. pp 97-119.
63. Kay MMB: Senescent cell differentiation antigen. Prog Clin Biol Res 1985:195:251-262.
64. Kay MMB: Senescent cell antigen: A terminal differentiation antigen. Surv Synth Pathol Res 1985:4:227-236.
65. Bennett GD, Kay MMB: Homeostatic removal of senescent murine erythrocytes by splenic macrophages. Exp Hematol 1981;9:297-307.
66. Pctz LD, Yam P, Wilkinson L, Gar-ratty G, Lubin B, Mentzer W: Increased IgG molecules bound to the surface of red blood cells of patients with sickle cell anemia. Blood 1984; 64:301-304.
67. Hebbel RP, Miller WJ: Phagocytosis of sickle erythrocytes: Immunologic and oxidative determinants of hemolytic anemia. Blood 1984:64: 733-741.
68. Friedman MJ, Fukuda M, Laine RA: Evidence for a malarial parasite interaction site on the major trans-membrane protein of the human erythrocyte. Science 1985:228:75-77.
69. Marchalonis JJ, Schluter SF, Wilson L, Yocum DE, Boyer JT, Kay MM: Natural human antibodies to synthetic peptides autoantigens: Correlations with ageand autoimmune disease. Gerontology 1993:39:65-79.
70. Barker RN, Casswell KM, Elson CJ: Identification of murine erythrocyte autoantigens and cross-reactive rat antigens. Immunology 1993;78: 568-573.
71. Barker RN, de Sa Oliveira GG, Flson CJ, Lydyard PM: Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol 1993:23: 1723-1726.
72. Ando K, Beppu M, Kikugawa K, Hamasaki N: Increased susceptibility of stored erythrocytes to antiband 3 IgG autoantibody binding. Biochim Biophys Acta 1993:1178: 127-134.
73. Poulin J, Cover C, Gustafson M, Kay MMB: Vitamin E prevents oxidative modification of band 3 related proteins and subsequent generation of senescent cell antigen during aging. Proc Natl Acad Sci USA 1996;93:5600-5603.
74. Bosnian G, Bartholomeus I, de Grip W: Alzheimer’s disease and cellular aging: Membrane-related events as clues to primary mechanisms. Gerontology 1991;37:95-112.
75. Bosnian GJ, Bartholomeus IG, Dc Grip WJ: Alzheimer’s disease and cellular aging: Membrane-related events as clues to primary mechanisms. Gerontology 1991:37:95-112.
76. Bosnian GJ, Bartholomeus IG, De Man AJ, Van Kalmthout PJ, De Grip WJ: Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer’s disease. Neurobiol Aging 1991;12:13-18.
77. Bosnian GJ, van Workum FP, Ren-kawek K, Van Kalmthout PJ, Bar-tholomcus IG, Dc Grip WJ: Proteins immunologically related to erythrocyte anion transporter band 3 arc altered in brain areas affected by Alzheimer’s disease. Acta Ncuro-patliol 1993:86:353-359.
78. Bosman GJ, Visser FE, De Man AJ, Bartholomeus IG, De Grip WJ: Erythrocyte membrane changes of individuals with Down’s syndrome in various stages of Alzheimer-type dementia. Neurobiol Aging 1993; 14:223-228.
79. Kay MM, Bosnian GJ: Naturally occurring human ‘antigalactosyl’ IgG antibodies are heterophile antibodies recognizing blood-group-related substances. Exp Hematol 1985:13:1103-1112.
80. Kay M B, Cover C, Schluter S, Bernstein R, Marchalonis J: Band 3, the anion transporter is conserved during evolution: Implications for aging and vertebrate evolution. Cell Mol Biol 1995;41:833-842.
81. Kay MMB, Cover C, Wyant T: Human ervtliroid band 3. ‘anion exchanger 1’, is expressed in transformed lymphocytes. Cell Mol Biol 1996;in press.
82. Kay MMB, Lin F, Bosman G, Marchalonis JJ, Schluter SF: Human erythrocyte aging: Cellular and molecular biology. Trans Med Rev 1991;5:173-195.
83. Kay MMB, Bosman G, Johnson RC, Poulin J, Goodman J: Molecular basis of human band 3 mutation associated with increased anion transport. Exp Clin Immunogenet 1993;11:209-221.
84. Kay MMB: Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptides. J Prot Chem 1992; 1 1:595-602.
85. Kay MMB: Molecular mapping of human band anion transport regions using synthetic peptides. FASEB J 1990:5:109-115.
86. Kay MMB, Marchalonis JJ, Hughes J, Watanabe K, Schluter SF: Definition of a physiologic aging auto-antigen using synthetic peptides of membrane protein band 3: Localization of the active antigenic sites. Proc Natl Acad Sci USA 1990:87: 5734-5738.
87. Kay MMB, Lake D, Cover C: Band 3 and its peptides during aging, radiation exposure, and Alzheimer’s disease: Alterations and self-recognition. Adv Exp Med Biol 1995:383: 167-193.
88. Salhanv JM, Schoppfer LM, Kay MMB, Gamble D, Lawrence C: Differential sensitivity of stilbcncdisul-fonates in their interaction with band 3 HT (pro 868-leu). Proc Natl Acad Sci USA 1995:92:11844-11848.
89. Bruce L, Kay MMB, Lawrence C, Tanner MJA: Band 3 HT, a human red cell variant associated with acanthocytosis and increased anion transport, carries the mutation pro-868 to leu in the membrane domain of band 3. Biochem J 1993:293: 317-320.
90. Kay MMB, Bosman GJCGM, Lawrence C: Functional topography of band 3: A specific structural alteration linked to functional aberrations in human erythrocytes. Proc Natl Acad Sci USA 1988:85:492-496.
91. Bosman GJCGM, Kay MMB: Alterations of band 3 transport protein by cellular aging and disease: Erythrocyte band 3 and glucose transporter share a functional relationship. Biochem Cell Biol 1990:68:1419-1427.
92. Steck TL: The organization of proteins in human red blood cell membranes. J Cell Biol 1974:62:1-19.
93. Goodman SR, Shiffer K: The spectrin membrane skeleton of normal and abnormal human erythrocytes: A review. Am J Physiol 1983;244:C121-C141.
94. Tievet B, Gabillat N, Borgesc F, Motais R: Expression of band 3 anion exchanger induces chloride current and taurine transport: Structure-function analysis. EM BO J 1995;14:5158-5169.
95. + channel current that is activated by cell swelling, cAMP, and glyburide in insulin-secreting cells. Diabetes 1995:44:1461-1466.
96. McKhann G, Drachman D, Fol-stein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease. Neurology 1984:34:939-944.
97. Kay MMB: glucose transport protein is structurally and immuno-logically related to band 3 and senescent cell antigen. Proc Natl Acad Sci USA 1985:82:1731-1735.
98. Kay MMB: Anti-idiotypic antibodies as membrane probes: Is the glucose transporter related to the anion transporter band 3? In Lith-icum DS, Farid N (eds): Anti-ldio-types, Receptors and Molecular Mimicry. New York. Springer. 1988 pp 231-244.
99. Banchercau J, Rousset F: Growing human B lymphocytes in the CD40 system. Nature 1991:353: 678-679.
100. Banchercau J, Dc Paoli P, Valle A, Garcia E, Rousett F: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1990;251:70-72.
101. Darveau A, Chevrier MC, Neron S, Delage R, Lemieux R: Efficient preparation of human monoclonal antibody-seceting heterohybrido-mas using peripheral B lymphocytes cultured in the CD40 system. J Immunol Meth 1993:159:139-143.
102. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Oclts HD: B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993:178: 1097-1102.
103. Galibert L, Durand I, Banchercau J, Rousset F: CD40-activatcd surface IgD-positive lymphocytes consitute the long term Il.-4-de-pendent proliferating B cell pool. J Immunol 1994:152:22-29.
104. Coligan JF„ Kruisbeek AM, Mar-guiles DH, Shevach E, Strober W: Current Protocols in Immunology. New York. Green Publishing/Wiley-1 nterscicnce. 1992.
105. Thompson KM, Hough DW, Mad-dison PJ, Melamed MD, Huglies-Jones N: The efficient production of stable human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. J Immunol 1986:94:7-12.
106. Kay MMB: Cellular and molecular biology of an aging antigen; in Gar-ratv G (ed): Immunobiology of Transfusion Medicine. New York. Marcel Dekker, 1993. pp 173-198.
107. Kay MMB: Drosophila to bacteriophage to erythrocyte: The erythrocyte as a model for mclecular and membrane aging of terminally differentiated cells. Gerontology 1991;37:5-32.
108. Kay MMB: Multiple labeling technique used for studies of activated human B lymphocytes. Nature 1975;254:424-426.
109. Kay MMB: Kupfier cells: Homeostatic functions during aging; in Platt D (ed): Liver and Aging. Stuttgart, Schattauer. 1977, pp 87-113.
110. Cianci CD, Giorgi M, Morrow JS: Phosphorylation of ankyrin down-regulates its cooperative interaction with spectrin and protein 3. J Cell Biochem 1988:37:301-315.
111. Baggio B, Bordin L, Clari G, Gam-baro G, Morct V: Functional correlation between the Ser/Thr-phos-porylation of band-3 and band-3-mcdiated transmembrane anion transport in human erythrocytes. Biochim Biophys Acta 1993:1148: 157-160.
112. Baggio B, Bordin L, Gambaro G, Piccoli A, Marzaro G, Clari G: Evidence of a link between erythrocyte band 3 phosphory lation and anion transport in patients with’idiopathic’ calcium oxalate nephrolithiasis. Miner Electrolyte Me-tab 1993:19:17-20.
113. Bosman GJ, Renkawck K, van Workum FP, Bartholomeus IG, De Grip WJ: The involvement of neuronal anion exchange proteins in cell death in Alzheimer’s disease. Gerontology, in press.
114. McRae AM, Ling EA, Polinsky R, Gottfries CG, Dahlstrom A: Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system. Neuroscience 1991:41:739-752.
115. McRae A, Dahlstrom A: Cerebrospinal fluid antibodies: An indicator for immune responses in Alzheimer’s disease. Res Immunol 1992;143:663-667.
116. Ling EA, Dahlstrom A, Polinsky RJ, Nee LE, McRae R: Studies of activated microglial cells and macrophages using Alzheimer's disease cerebrospinal fluid in adult rats with experimentally induced lesions. Neuroscience 1992:51: 815-825.
117. McRae A, Dahlstrom A, Ling EA: Microglia in ncurodegcnerativc disorders: Emphasis on Alzheimer's disease. Gerontology, in press.
118. Perry FF, Barker RN, Mazza G, Day MJ, Wells AD, Shen CR, Schofield AE, Elson CJ: Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse. Eur J Immunol 1996: 26:136-141.
119. Glass GA, Gershon H, Gershon D: The effect of donor and cell age on several characteristics of rat erythrocytes. Exp Hematol 1983; 11: 897-995.
120. Glass GA, Gershon D, Gershon H: Some characteristics of the human erythrocyte as a function of donor and cell age. Exp Hematol 1985; 13:1122-1126.
121. Johnson RM, Tang K: DIDS inhibition of deformation-induced cation flux in human erythrocytes. Biochim Biophys Acta 1993:1148: 7-14.